Recent Progress in the Development of Opaganib for the Treatment of Covid-19
Covid-19 치료를 위한 Opaganib 개발의 최근 진행 상황
Review
[키워드] ABC294640
acceleration
active against
Administered
Anti-SARS-CoV-2 Activity
Antiviral
antiviral activity
biochemical
Cancer
clearance
clinical trial
COVID-19 pandemic
decrease
demonstrated
development
dihydroceramide desaturase
disease
driven by
drug
enzyme
glucosylceramide
glucosylceramide synthase
Host
Infection
Inflammation
Inflammatory diseases
inhibit
inhibiting
mechanism
metabolism
Mild
Mild disease
moderate
moderately severe COVID-19
modulation
Mortality
multi-organ dysfunction
opaganib
pandemic
pathologic
pathologic processes
Patient
patients
patients hospitalized
phase
Progress
recent
regulate
Replication
replication of SARS-CoV-2
SARS-CoV-2
SARS-CoV-2 virus
Signaling
sphingolipid
sphingolipids
sphingosine
sphingosine kinase.
Stress
subpopulation
suppresse
the SARS-CoV-2 virus
treat
Treatment
treatment protocols
understanding
viral proliferation
virus
[DOI] 10.2147/DDDT.S367612 PMC 바로가기 [Article Type] Review
[DOI] 10.2147/DDDT.S367612 PMC 바로가기 [Article Type] Review